Document


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


Form 8-K


CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934

June 23, 2016
Date of Report (Date of earliest event reported)

 
 
 
HEALTHEQUITY, INC.
 
 
 
(Exact name of registrant as specified in its charter)

Delaware
 
7389
 
52-2383166
(State or other jurisdiction of
incorporation or organization)
 
(Commission File Number)
 
(I.R.S. Employer
Identification Number)

15 West Scenic Pointe Drive
Suite 100
Draper, Utah 84020
(Address of principal executive offices) (Zip Code)

(801) 727-1000
(Registrants telephone number, including area code)
 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2):
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 




Item 5.07. Submission of Matters to a Vote of Security Holders.
 
On June 23, 2016, HealthEquity, Inc. (the “Company”) held its 2016 Annual Meeting of Stockholders (the “Annual Meeting”). As of the close of business on April 25, 2016, the record date for the Annual Meeting, 57,942,472 shares of common stock of the Company were issued and outstanding and entitled to vote at the Annual Meeting. At the Annual Meeting, the stockholders voted on two proposals, each of which is described in more detail in the Company’s definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on May 10, 2016. Stockholders approved each of the proposals presented for a vote. The tables below set forth the number of votes cast for and against or withheld, and the number of abstentions or broker non-votes, for each matter voted upon by the Company’s stockholders.

1.
Proposal 1. The election of eight directors to hold office until the 2017 Annual Meeting of Stockholders or until their successors are duly elected and qualified.

Nominees
For

Withhold Authority

Broker
 Non-Vote

Robert W. Selander
47,342,127

208,972

8,960,587

Jon Kessler
47,225,445

325,654

8,960,587

Stephen D. Neeleman, M.D.
47,225,446

325,653

8,960,587

Frank A. Corvino
47,176,334

374,765

8,960,587

Evelyn Dilsaver
47,225,513

325,586

8,960,587

Michael O. Leavitt
47,213,357

337,742

8,960,587

Frank T. Medici
33,389,307

14,161,792

8,960,587

Manu Rana
33,544,236

14,006,863

8,960,587

Ian Sacks
33,061,457

14,489,642

8,960,587


2.
Proposal 2. The ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending January 31, 2017.

For
Against
Abstain
56,302,871
20,206
188,609








Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
HEALTHEQUITY, INC.
Dated: June 24, 2016
By:
/s/ Darcy Mott
 
 
 Darcy Mott
 
 
 Executive Vice President and Chief Financial Officer